Our Press Releases

An overview of Tofacitinib, the first FDA approved JAK inhibitor, and its Indications Introduction Tofacitinib

Introduction The JAK/STAT signaling pathway is an universally expressed intracellular signal transduction pathway; involved

Advances of Targeted Therapy for Hepatocellular Carcinoma Hepatocellular carcinoma (HCC) is categorized as one

Quick Review over Graft-versus-Host Disease (GvHD) Introduction: Graft-versus-Host Disease (GvHD) is a common complication

Introduction of Waldenstrom Macroglobulinemia (WM)   Waldenstrom Macroglobulinemia (WM) is a non-Hodgkin lymphoma (NHL),

Quick overview of Marginal Zone Lymphoma (MZL): Marginal zone lymphoma (MZL) which is also

Quick overview of Mantle cell lymphoma (MCL)   Mantle cell lymphoma (MCL) is grouped

Small Lymphocytic Lymphoma (SLL) overview:   Chronic lymphocytic leukemia (CLL) and Small Lymphocytic Lymphoma

Quick review over chronic lymphocytic leukemia (CLL) Chronic lymphocytic leukemia which is also called CLL